Quick Links
Connect with Us
Need Help? Have a Question?

UW Researcher Awarded $1.2M to Develop a 3-D Human Tissue Model

UW Researcher Awarded $1.2M to Develop a 3-D Human Tissue Model

The NIH has awarded $15M in funding to further their Tissue Chip Drug Screening program, which was launched by the National Center for Advancing Translational Sciences (NCATS) in 2012. Jonathan Himmelfarb, MD, Director of the Kidney Research Institute and UW Professor of Medicine, received one of these exciting awards in the amount of $1.2M to study a Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing.

NCATS supports the Tissue Chip Drug Screening program as part of its overall mission to expedite the clinical research process and get more treatment, to more patients, faster. “Tissue chips” have the potential to mimic complex biological functions and provide a new way to test drug efficacy before human clinical trials.

“The goal is for these tissue chips to provide more accurate platforms to understand diseases, and to be more predictive of the human response to drugs than current research models, thereby improving the success rate of candidate drugs in human clinical trials,” said NCATS Director Christopher P. Austin, MD.

Jonathan Himmelfarb, MD
Jonathan Himmelfarb, MD


Cite ITHSThe Institute is supported by grants UL1 TR002319, KL2 TR002317, and TL1 TR002318 from the NIH National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA).

Please help us continue to support your research by citing our grant number(s) in publications we supported.